Thomas Templeman Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Thomas Templeman is Chief Technology Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 188,244 shares of CNTA, which is worth approximately $3.2 Million. The most recent transaction as insider was on Mar 31, 2023, when has been sold 4,103 shares (Ordinary Shares) at a price of $3.9 per share, resulting in proceeds of $16,001. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 188K

0% 3M change

0% 12M change

Total Value Held $3.2 Million

Thomas Templeman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2023	SELL Payment of exercise price or tax liability	$16,001 $3.9 p/Share	4,103 Reduced 2.13%	188,244 Ordinary Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	60,400 Added 23.9%	192,347 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$9,055 $3.1 p/Share	2,921 Reduced 2.08%	137,329 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$9,697 $3.95 p/Share	2,455 Reduced 1.78%	135,792 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$22,873 $4.25 p/Share	5,382 Reduced 3.84%	134,868 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$8,152 $4.07 p/Share	2,003 Reduced 1.43%	138,247 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	140,000 Added 49.96%	140,250 Ordinary Shares
Jun 02 2021	BUY Open market or private purchase	$5,000 $20.0 p/Share	250 Added 50.0%	250 Ordinary Shares

Also insider at

NUVB

Nuvation Bio Inc. Healthcare

SVP, Pharmaceutical Ops